Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial

Date
2021
Author
Zeymer, Uwe
Leiva, Orly
Hohnloser, Stefan H.
Steg, Philippe Gabriel
Oldgren, Jonas
Ongen, Zeki
Estrada, Jose Navarro
Ophuis, Ton Oude
Lip, Gregory Y. H.
Nordaby, Matias
Miede, Corinna
ten Berg, Jurrien M.
Bhatt, Deepak L.
Cannon, Christopher P.
Nickenig, Georg
Kiss, Robert Gabor
Metadata
Show full item record
Abstract
Background: Little is known about the optimal antithrombotic therapy in patients with atrial fibrillation undergoing PCI for ST-elevation myocardial infarction (STEMI).
URI
http://hdl.handle.net/20.500.12627/172607
https://doi.org/10.4244/eij-d-20-00799
Collections